Tatva Chintan Pharma Chem reports consolidated net profit of Rs 9.92 crore in the September 2025 quarter
(31 Oct 2025)

Back
Net profit of Tatva Chintan Pharma Chem reported to Rs 9.92 crore in the quarter ended September 2025 as against net loss of Rs 0.66 crore during the previous quarter ended September 2024. Sales rose 47.95% to Rs 123.52 crore in the quarter ended September 2025 as against Rs 83.49 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales123.5283.49 48
OPM %17.986.68 -
PBDT22.725.79 292
PBT13.66-1.02 LP
NP9.92-0.66 LP

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew